Summary The Asia-Pacific region is home to more than half of the global population and
accounted for 62· 6% of global deaths due to liver diseases in 2015. 54· 3% of global deaths …

This review is an abbreviated version of a report prepared for the American Cancer Society
Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt …

Viral hepatitis is a major public health threat and a leading cause of death worldwide.
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …

Background and aim Hepatitis C virus infection can lead to an enormous health burden
worldwide. Investigating the changes in HCV-related burden between different countries …

Hepatitis C virus (HCV) is one of the leading causes of chronic liver disease, cirrhosis, and
hepatocellular carcinoma, resulting in major global public health concerns. The HCV …

Background There have been few reports on programmatic experience of viral hepatitis
testing and treatment in resource-limited settings. To inform the development of the 2017 …

Summary In 2015, the Coalition to Eradicate Viral Hepatitis in Asia Pacific gathered leading
hepatitis experts from Bangladesh, India, Indonesia, Malaysia, Pakistan, the Philippines, and …

Background & Aims The prevalence of anti-hepatitis C virus antibody in Punjab, India is
3.6%, with 728,000 people estimated to have viremic chronic hepatitis C (CHC). The Mukh …

Background We undertook this study to assess the incremental cost per quality adjusted life
year (QALY) gained with the use of pan-genotypic sofosbuvir (SOF)+ velpatasvir (VEL) for …

Viral hepatitis is a cause for major health care burden in India and is now equated as a
threat comparable to the “big three” communicable diseases–HIV/AIDS, malaria and …